Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > J. Ali Satvat > Profile

J. Ali Satvat

Affiliations

  • at Bridgebio Pharma Inc. (BBIO), 2024-12-31
  • Director at Impel Neuropharma Inc (IMPL), 2021-04-22
  • Director at Eidos Therapeutics Inc. (EIDX), 2021-01-29
  • Director at Coherus Biosciences Inc. (CHRS), 2020-01-14
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Eidos Therapeutics Inc.
 EIDX $29.90 882,353 Large Shareholder, Director 24,575,501 2019-07-03 Filing
Eidos Therapeutics Inc.
 EIDX $25.93 1,103,848 Large Shareholder, Director 23,693,148 2019-05-24 Filing
Eidos Therapeutics Inc.
 EIDX $13.96 2,664 Large Shareholder, Director 22,589,300 2018-12-10 Filing
Eidos Therapeutics Inc.
 EIDX $13.29 37,989 Large Shareholder, Director 22,586,636 2018-12-10 Filing
Eidos Therapeutics Inc.
 EIDX $14.36 4,860 Large Shareholder, Director 22,548,647 2018-12-07 Filing